Ticker: MIRM

Company: Mirum Pharmaceuticals, Inc.

Person: Christopher Peetz, director, officer

Transaction date: Nov. 18, 2025

Reporting date: Nov. 20, 2025

Average share price: 19.24

Bought 19133.0 shares for 368118.92